Mahesh GAİDHANE, Ajay GHATOLE, Kushal LANJEWAR, Kishor HATZADE

Innovational combination of hetero-bifunctional N-PEG quinoline scaffolds derivatives with improved anticancer activity against breast and colon cancer cell lines and P-glycoprotein, cytochrome p450 enzyme activity prediction

Polyethylene glycol (PEG) is a polymer that is widely used as a carrier for drug delivery systems (DDS). A library of N- PEGylated quinoline derivatives of PEG molecular weight 200 was prepared rapidly after the activation of PEGs using maleic anhydride. Quinoline with a polymer backbone is essential as new material. PEG is a water-soluble nonionic polymer approved by food and drug organizations for medicine applications. Because of its nontoxic grapheme, it is widely utilized in numerous biochemical, cosmetic, pharmaceutical, and industrialized applications. The modern SwissADME is a web tool that stretches free admittance to a pool of hasty, yet solid, clarifying models for physicochemical properties, pharmacokinetics, and therapeutic science. The present facile synthetic strategy can be a practical approach for incorporating polymeric carriers conjugated with drug moieties, either in the backbone of the polymer or as a terminal and pendant group on the polymer chains.

Keywords:

PEGylated quinoline breast, colon cancer, P-glycoprotein, cytochrome P450 enzyme,

PDF

___

Aghahosseini H, 2019, ASIAN J ORG CHEM, V8, P1519, DOI 10.1002/ajoc.201900241
ALLEN TM, 1994, ADV DRUG DELIVER REV, V13, P285, DOI 10.1016/0169-409X(94)90016-7
BLUME G, 1993, BIOCHIM BIOPHYS ACTA, V1149, P180, DOI 10.1016/0005-2736(93)90039-3
Brenk R, 2008, CHEMMEDCHEM, V3, P435, DOI 10.1002/cmdc.200700139
Caliceti P, 2003, BIOCONJUGATE CHEM, V14, P899, DOI 10.1021/bc034080i
Chandrasekhar S, 2002, ORG LETT, V4, P4399, DOI 10.1021/ol0266976
Coessens V, 1997, J CONTROL RELEASE, V47, P283, DOI 10.1016/S0168-3659(97)01655-6
Daina A, 2017, SCI REP-UK, V7, DOI 10.1038/srep42717
Delaney JS, 2004, J CHEM INF COMP SCI, V44, P1000, DOI 10.1021/ci034243x
Dube D, 1998, BIOORG MED CHEM LETT, V8, P1255, DOI 10.1016/S0960-894X(98)00201-7
Egan WJ, 2000, J MED CHEM, V43, P3867, DOI 10.1021/jm000292e
Fagerberg JH, 2015, PHARM RES-DORDR, V32, P578, DOI 10.1007/s11095-014-1487-z
Gaidhane MK, 2020, POLYM SCI SER B+, V62, P206, DOI 10.1134/S1560090420030045
Gaidhane MK, 2013, INT J PHARM PHARM SC, V5, P421
Ghatole A, 2014, INT J PHARM PHARM SC, V6, P142
Ghatole A M, 2015, INT J RES BIOSC AGR, V1, P89
Ghatole A. M., 2014, WORLD J PHARM RES, V3, P4336
Ghatole AM, 2015, SPECTROCHIM ACTA A, V151, P515, DOI 10.1016/j.saa.2015.06.035
Ghatole AM, 2020, J SCI ED, V29, P206 .
Ghose AK, 1999, J COMB CHEM, V1, P55, DOI 10.1021/cc9800071
Gupta R, 1998, INDIAN J CHEM B, V37, P1211
Gupta R, 2000, INDIAN J CHEM B, V39, P847
Harris JM, 1998, J ORG CHEM, V63, P2407, DOI 10.1021/jo972304i
HERMAN S, 1995, J BIOACT COMPAT POL, V10, P145, DOI 10.1177/088391159501000205
Hosseinzadeh Z, 2020, TURK J CHEM, V44, P194, DOI 10.3906/kim-1903-72
Hosseinzadeh Z, 2019, TURK J CHEM, V43, P464, DOI 10.3906/kim-1807-101
Jia ZF, 2003, BIOORG MED CHEM LETT, V13, P2531, DOI 10.1016/S0960-894X(03)00470-0
Leenders F, 2006, BIOPHARMACEUTICALS, P39
Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0
Muegge I, 2001, J MED CHEM, V44, P1841, DOI 10.1021/jm015507e
Ogu C C, 2000, Proc (Bayl Univ Med Cent), V13, P421
Roberts MJ, 2002, ADV DRUG DELIVER REV, V54, P459, DOI 10.1016/S0169-409X(02)00022-4
Roseeuw E, 1999, J MATER SCI-MATER M, V10, P743, DOI 10.1023/A:1008991508877
Veber DF, 2002, J MED CHEM, V45, P2615, DOI 10.1021/jm020017n
Veronese FM, 2008, BIODRUGS, V22, P315, DOI 10.2165/00063030-200822050-00004
Wentworth P, 1997, CHEM COMMUN, P759 .
Wipf P, 1996, TETRAHEDRON LETT, V37, P4659, DOI 10.1016/0040-4039(96)00918-5
WOODLE MC, 1992, BIOCHIM BIOPHYS ACTA, V1113, P171, DOI 10.1016/0304-4157(92)90038-C
Yang ML, 2001, BIOMACROMOLECULES, V2, P134, DOI 10.1021/bm000087g
ZALIPSKY S, 1995, ADV DRUG DELIVER REV, V16, P157, DOI 10.1016/0169-409X(95)00023-Z